L. Lagging, K. Meyer, R. Owens, and R. Ray, Functional role of hepatitis C virus chimeric glycoproteins in the infectivity of pseudotyped virus, J Virol, vol.72, pp.3539-3546, 1998.

T. Wakita, T. Pietschmann, T. Kato, T. Date, M. Miyamoto et al., Production of infectious hepatitis C virus in tissue culture from a cloned viral genome, Nature Medicine, vol.37, issue.7, pp.791-796, 2005.
DOI : 10.1002/jmv.10297

R. Hynes, D. Burton, J. Mckeating, and C. Rice, Complete replication of hepatitis C virus in cell culture, Science, vol.309, pp.623-626, 2005.

J. Zhong, P. Gastaminza, G. Cheng, S. Kapadia, T. Kato et al., Robust hepatitis C virus infection in vitro, Proceedings of the National Academy of Sciences, vol.102, issue.26, pp.9294-9299, 2005.
DOI : 10.1073/pnas.0503596102

H. Barth, C. Schäfer, M. Adah, F. Zhang, R. Linhardt et al., Cellular Binding of Hepatitis C Virus Envelope Glycoprotein E2 Requires Cell Surface Heparan Sulfate, Journal of Biological Chemistry, vol.278, issue.42
DOI : 10.1074/jbc.M302267200

D. Rosa, S. Campagnoli, C. Moretto, E. Guenzi, L. Cousens et al., A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells., Proc. Natl. Acad. Sci, 1996.
DOI : 10.1073/pnas.93.5.1759

V. Ghisetti, B. Lavezzo, H. Blum, F. Von-weizsacker, A. Vitelli et al., Scavenger receptor class B type I and hepatitis C virus infection of primary tupaia hepatocytes, J Virol, vol.79, pp.5774-5785, 2005.

T. Baumert, Uptake and presentation of hepatitis C virus-like particles by human dendritic cells, Blood, vol.105, pp.3605-3614, 2005.

T. Liang, Interaction of hepatitis C virus-like particles and cells: a model system for studying viral binding and entry, J. Virol, vol.76, pp.9335-9344, 2002.

M. Triyatni, J. Vergalla, A. Davis, K. Hadlock, S. Foung et al., Structural Features of Envelope Proteins on Hepatitis C Virus-like Particles as Determined by Anti-envelope Monoclonal Antibodies and CD81 Binding, Virology, vol.298, issue.1, pp.124-132, 2002.
DOI : 10.1006/viro.2002.1463

H. Barth, E. Schnober, F. Zhang, R. Linhardt, E. Depla et al., Viral and Cellular Determinants of the Hepatitis C Virus Envelope-Heparan Sulfate Interaction, Journal of Virology, vol.80, issue.21, pp.10579-10590, 2006.
DOI : 10.1128/JVI.00941-06

B. Bartosch, J. Bukh, J. Meunier, C. Granier, R. Engle et al., In vitro assay for neutralizing antibody to hepatitis C virus: Evidence for broadly conserved neutralization epitopes, Proceedings of the National Academy of Sciences, vol.100, issue.24, pp.14199-14204, 2003.
DOI : 10.1073/pnas.2335981100

B. Bartosch, G. Verney, M. Dreux, P. Donot, Y. Morice et al., An interplay between hypervariable region 1 of the hepatitis C virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both 14

J. Meunier, R. Engle, K. Faulk, M. Zhao, B. Bartosch et al., Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1, Proceedings of the National Academy of Sciences, vol.102, issue.12, pp.4560-4565, 2005.
DOI : 10.1073/pnas.0501275102

J. Pestka, M. Zeisel, E. Blaser, P. Schurmann, B. Bartosch et al., Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C, Proceedings of the National Academy of Sciences, vol.104, issue.14, pp.6025-6030, 2007.
DOI : 10.1073/pnas.0607026104

URL : https://hal.archives-ouvertes.fr/inserm-00395910

J. Dubuisson and C. Voisset, The neutralizing activity of anti-HCV antibodies is modulated by specific glycans on the E2 envelope protein, J Virol, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00183359

L. Buonocore, K. Blight, C. Rice, and J. Rose, Characterization of Vesicular Stomatitis Virus Recombinants That Express and Incorporate High Levels of Hepatitis C Virus Glycoproteins, Journal of Virology, vol.76, issue.14, pp.6865-6872, 2002.
DOI : 10.1128/JVI.76.14.6865-6872.2002

K. Meyer, A. Beyene, T. Bowlin, A. Basu, and R. Ray, Coexpression of Hepatitis C Virus E1 and E2 Chimeric Envelope Glycoproteins Displays Separable Ligand Sensitivity and Increases Pseudotype Infectious Titer, Journal of Virology, vol.78, issue.23, pp.12838-12847, 2004.
DOI : 10.1128/JVI.78.23.12838-12847.2004

B. Lindenbach, P. Meuleman, A. Ploss, T. Vanwolleghem, A. Syder et al., Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro, Proceedings of the National Academy of Sciences, vol.103, issue.10, pp.3805-3809, 2006.
DOI : 10.1073/pnas.0511218103

T. Pietschmann, A. Kaul, G. Koutsoudakis, A. Shavinskaya, S. Kallis et al., Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras, Proceedings of the National Academy of Sciences, vol.103, issue.19, pp.7408-7413, 2006.
DOI : 10.1073/pnas.0504877103

M. Yi, R. Villanueva, D. Thomas, T. Wakita, and S. Lemon, Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells, Proceedings of the National Academy of Sciences, vol.103, issue.7, pp.2310-2315, 2006.
DOI : 10.1073/pnas.0510727103

J. Bukh, A critical role for the chimpanzee model in the study of hepatitis C, Hepatology, vol.173, issue.6, pp.1469-1475, 2004.
DOI : 10.1002/hep.20268

P. Farci, H. Alter, D. Wong, R. Miller, S. Govindarajan et al., Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization., Proceedings of the National Academy of Sciences, vol.91, issue.16, pp.7792-7796, 1994.
DOI : 10.1073/pnas.91.16.7792

P. Farci, A. Shimoda, D. Wong, T. Cabezon, D. Gioannis et al., Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein, Proceedings of the National Academy of Sciences, vol.93, issue.26
DOI : 10.1073/pnas.93.26.15394

Q. Choo, G. Kuo, R. Ralston, A. Weiner, D. Chien et al., Vaccination of chimpanzees against infection by the hepatitis C virus., Proceedings of the National Academy of Sciences, vol.91, issue.4
DOI : 10.1073/pnas.91.4.1294

S. Desai, R. Miller, and N. Ogata, Lack of protective immunity against reinfection with hepatitis C virus, Science, vol.258, pp.135-140, 1992.

A. Prince, B. Brotman, T. Huima, D. Pascual, M. Jaffery et al., Immunity in Hepatitis C Infection, Journal of Infectious Diseases, vol.165, issue.3, pp.438-443, 1992.
DOI : 10.1093/infdis/165.3.438

S. Bassett, B. Guerra, K. Brasky, E. Miskovsky, M. Houghton et al., Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection, Hepatology, vol.33, issue.6, pp.1479-1487, 2001.
DOI : 10.1053/jhep.2001.24371

M. Major, K. Mihalik, M. Puig, B. Rehermann, M. Nascimbeni et al., Previously Infected and Recovered Chimpanzees Exhibit Rapid Responses That Control Hepatitis C Virus Replication upon Rechallenge, Journal of Virology, vol.76, issue.13, pp.6586-6595, 2002.
DOI : 10.1128/JVI.76.13.6586-6595.2002

R. Lanford, B. Guerra, D. Chavez, C. Bigger, K. Brasky et al., Cross-Genotype Immunity to Hepatitis C Virus, Journal of Virology, vol.78, issue.3, pp.1575-1581, 2004.
DOI : 10.1128/JVI.78.3.1575-1581.2004

G. Koutsoudakis, A. Kaul, E. Steinmann, S. Kallis, V. Lohmann et al., Characterization of the Early Steps of Hepatitis C Virus Infection by Using Luciferase Reporter Viruses, Journal of Virology, vol.80, issue.11, pp.5308-5320, 2006.
DOI : 10.1128/JVI.02460-05

M. Zeisel, G. Koutsoudakis, E. Schnober, A. Haberstroh, H. Blum et al., Scavenger receptor BI is a key host factor for Hepatitis C virus infection required for an entry step closely linked to CD81 Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry, Nature, vol.446, pp.801-805, 2007.

E. Blanchard, S. Belouzard, L. Goueslain, T. Wakita, J. Dubuisson et al., Hepatitis C Virus Entry Depends on Clathrin-Mediated Endocytosis, Journal of Virology, vol.80, issue.14, pp.6964-6972, 2006.
DOI : 10.1128/JVI.00024-06

URL : https://hal.archives-ouvertes.fr/hal-00105504

L. Meertens, C. Bertaux, and T. Dragic, Hepatitis C Virus Entry Requires a Critical Postinternalization Step and Delivery to Early Endosomes via Clathrin-Coated Vesicles, Journal of Virology, vol.80, issue.23, pp.11571-11578, 2006.
DOI : 10.1128/JVI.01717-06

A. 50-codran, C. Royer, D. Jaeck, M. Bastien-valle, T. Baumert et al., Entry of hepatitis C virus pseudotypes into primary human hepatocytes by clathrin-dependent endocytosis, Journal of General Virology, vol.87, issue.9, pp.2583-2593, 2006.
DOI : 10.1099/vir.0.81710-0

D. Tscherne, C. Jones, M. Evans, B. Lindenbach, J. Mckeating et al., Time- and Temperature-Dependent Activation of Hepatitis C Virus for Low-pH-Triggered Entry, Journal of Virology, vol.80, issue.4, pp.1734-1741, 2006.
DOI : 10.1128/JVI.80.4.1734-1741.2006

H. Barth, T. Liang, and T. Baumert, Hepatitis C virus entry: Molecular biology and clinical implications, Hepatology, vol.7, issue.3, pp.527-535, 2006.
DOI : 10.1002/hep.21321

P. Klasse and Q. Sattentau, Occupancy and mechanism in antibody-mediated neutralization of animal viruses, Journal of General Virology, vol.83, issue.9, pp.2091-2108, 2002.
DOI : 10.1099/0022-1317-83-9-2091

A. Owsianka, A. Tarr, V. Juttla, D. Lavillette, B. Bartosch et al., Monoclonal Antibody AP33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E2 Envelope Glycoprotein, Journal of Virology, vol.79, issue.17, pp.11095-11104, 2005.
DOI : 10.1128/JVI.79.17.11095-11104.2005

J. Zhang, G. Randall, A. Higginbottom, P. Monk, C. Rice et al., CD81 Is Required for Hepatitis C Virus Glycoprotein-Mediated Viral Infection, Journal of Virology, vol.78, issue.3, pp.1448-1455, 2004.
DOI : 10.1128/JVI.78.3.1448-1455.2004

K. Szewczyk, B. Thomson, A. Patel, and J. Ball, Identification of conserved residues in the E2 envelope glycoprotein of the hepatitis C virus that are critical for CD81 binding, J Virol, vol.80, pp.8695-8704, 2006.

F. Habersetzer, A. Fournillier, J. Dubuisson, D. Rosa, S. Abrignani et al., Characterization of Human Monoclonal Antibodies Specific to the Hepatitis C Virus Glycoprotein E2 within VitroBinding Neutralization Properties, Virology, vol.249, issue.1, pp.32-41, 1998.
DOI : 10.1006/viro.1998.9202

D. Schofield, B. Bartosch, Y. Shimizu, T. Allander, H. Alter et al., Human monoclonal antibodies that react with the E2 glycoprotein of hepatitis C virus and possess neutralizing activity, Hepatology, vol.78, issue.7959, pp.1055-1062, 2005.
DOI : 10.1002/hep.20906

A. Op-de-beeck, C. Voisset, B. Bartosch, Y. Ciczora, L. Cocquerel et al., Characterization of Functional Hepatitis C Virus Envelope Glycoproteins, Journal of Virology, vol.78, issue.6
DOI : 10.1128/JVI.78.6.2994-3002.2004

A. Tarr, A. Owsianka, J. Timms, C. Mcclure, R. Brown et al., Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33, Hepatology, vol.399, issue.3, pp.592-601, 2006.
DOI : 10.1002/hep.21088

D. Lavillette, . Donot, J. Fresquet, J. Molle, . Corbau et al., Characterization of Fusion Determinants Points to the Involvement of Three Discrete Regions of Both E1 and E2 Glycoproteins in the Membrane Fusion Process of Hepatitis C Virus, Journal of Virology, vol.81, issue.16
DOI : 10.1128/JVI.02642-06

H. Diepolder, R. Zachoval, R. Hoffmann, E. Wierenga, T. Santantonio et al., Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection, The Lancet, vol.346, issue.8981, pp.1006-1007, 1995.
DOI : 10.1016/S0140-6736(95)91691-1

R. Thimme, D. Oldach, K. Chang, C. Steiger, S. Ray et al., Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection, The Journal of Experimental Medicine, vol.43, issue.10, pp.1395-1406, 2001.
DOI : 10.1126/science.284.5415.825

C. Feray, M. Gigou, D. Samuel, B. Ducot, P. Maisonneuve et al., Incidence of Hepatitis C in Patients Receiving Different Preparations of Hepatitis B Immunoglobulins after Liver Transplantation, Annals of Internal Medicine, vol.128, issue.10, pp.810-816, 1998.
DOI : 10.7326/0003-4819-128-10-199805150-00003

H. Chapel, J. Christie, V. Peach, and R. Chapman, Five-Year Follow-up of Patients with Primary Antibody Deficiencies Following an Outbreak of Acute Hepatitis C, Clinical Immunology, vol.99, issue.3, pp.320-324, 2001.
DOI : 10.1006/clim.2001.5036

J. Christie, C. Healey, J. Watson, V. Wong, M. Duddridge et al., Clinical outcome of hypogammaglobulinaemic patients following outbreak of acute hepatitis C: 2 year follow up, Clinical and Experimental Immunology, vol.110, issue.1, pp.4-8, 1997.
DOI : 10.1111/j.1365-2249.1997.508-ce1412.x

M. Yu, B. Bartosch, P. Zhang, Z. Guo, P. Renzi et al., Neutralizing antibodies to hepatitis C virus (HCV) in immune globulins derived from anti-HCV-positive plasma, Proceedings of the National Academy of Sciences, vol.101, issue.20, pp.7705-7710, 2004.
DOI : 10.1073/pnas.0402458101

C. Logvinoff, M. Major, D. Oldach, S. Heyward, A. Talal et al., Neutralizing antibody response during acute and chronic hepatitis C virus infection, Proceedings of the National Academy of Sciences, vol.101, issue.27, pp.10149-10154, 2004.
DOI : 10.1073/pnas.0403519101

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC454180

D. Netski, T. Mosbruger, E. Depla, G. Maertens, S. Ray et al., Humoral Immune Response in Acute Hepatitis C Virus Infection, Clinical Infectious Diseases, vol.41, issue.5, pp.667-675, 2005.
DOI : 10.1086/432478

D. Lavillette, Y. Morice, G. Germanidis, P. Donot, A. Soulier et al., Human Serum Facilitates Hepatitis C Virus Infection, and Neutralizing Responses Inversely Correlate with Viral Replication Kinetics at the Acute Phase of Hepatitis C Virus Infection, Journal of Virology, vol.79, issue.10, pp.6023-6034, 2005.
DOI : 10.1128/JVI.79.10.6023-6034.2005

M. Dreux, T. Pietschmann, C. Granier, C. Voisset, R. -. Blum et al., High Density Lipoprotein Inhibits Hepatitis C Virus-neutralizing Antibodies by Stimulating Cell Entry via Activation of the Scavenger Receptor BI, Journal of Biological Chemistry, vol.281, issue.27, pp.18285-18295, 2006.
DOI : 10.1074/jbc.M602706200

URL : https://hal.archives-ouvertes.fr/hal-00313930

L. Hangartner, B. Senn, B. Ledermann, U. Kalinke, P. Seiler et al., Antiviral immune responses in gene-targeted mice expressing the immunoglobulin heavy chain of virus-neutralizing antibodies, Proceedings of the National Academy of Sciences, vol.100, issue.22, pp.12883-12888, 2003.
DOI : 10.1073/pnas.2135542100

A. Ciurea, P. Klenerman, L. Hunziker, E. Horvath, B. Senn et al., Viral persistence in vivo through selection of neutralizing antibody-escape variants, Proceedings of the National Academy of Sciences, vol.97, issue.6, pp.2749-2754, 2000.
DOI : 10.1073/pnas.040558797

A. Takaki, M. Wiese, G. Maertens, E. Depla, U. Seifert et al., Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C, Nat. Med, vol.6, pp.578-582, 2000.

D. Bowen and C. Walker, Adaptive immune responses in acute and chronic hepatitis C virus infection, Nature, vol.38, issue.7053, pp.946-952, 2005.
DOI : 10.1128/JVI.78.3.1575-1581.2004

P. Kwong, M. Doyle, D. Casper, C. Cicala, S. Leavitt et al., HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites, Nature, vol.85, issue.6916, pp.678-682, 2002.
DOI : 10.1128/JVI.74.4.1961-1972.2000

S. Munoz, A. Balestrieri, R. Purcell, and H. Alter, The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies, Science, vol.288, pp.339-344, 2000.

I. Srivastava, J. Ulmer, and S. Barnett, Role of Neutralizing Antibodies in Protective Immunity Against HIV, Human Vaccines, vol.1, issue.2, pp.45-60, 2005.
DOI : 10.4161/hv.1.2.1764

A. Fournillier, C. Wychowski, D. Boucreux, T. Baumert, J. Meunier et al., Induction of Hepatitis C Virus E1 Envelope Protein-Specific Immune Response Can Be Enhanced by Mutation of N-Glycosylation Sites, Journal of Virology, vol.75, issue.24, pp.12088-12097, 2001.
DOI : 10.1128/JVI.75.24.12088-12097.2001

M. Flint, C. Maidens, L. Loomis-price, C. Shotton, J. Dubuisson et al., Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor CD81, J. Virol, vol.73, pp.6235-6244, 1999.